Ashish Tripathi

Ashish Tripathi

Ashish Tripathi is the Founder and CEO of Tzar Labs, Singapore, and Chairman of Epigeneres Biotech, India. He leads innovation in molecular diagnostics and precision medicine, focusing on early disease detection. 

Tzar Labs has developed a novel pan-cancer blood test for early detection across multiple cancer types, including solid and hematological malignancies. The platform targets detection at pre-stage I and early-stage disease with high sensitivity.  

Ashish is driving the company’s global expansion, with ongoing clinical studies in collaboration with the UK’s NHS and proof-of-concept work in the United States. 

The company’s research has been published in peer-reviewed journals, including Springer (2021) and Oxford’s Stem Cell (2023), and is supported by granted U.S. patents. 

 Ashish holds an MBA from Melbourne Business School and brings over 20 years of global experience in investment banking, M&A, and corporate strategy, having worked with leading firms including Edelweiss, Ernst & Young, Avendus, Deutsche Bank, and Deloitte. 

Share this speaker
Share This Speaker
  • Organization
    Tzar Labs
  • Profession
    Founder and CEO
Related sessions
In person
10 July 2026
15:00 - 15:30
EST - New York
CST - Beijing
PST - Los Angeles
AWST - Perth, Australia

Are you sure you want to remove this speaker?